parkinsonian

(redirected from parkinsonian syndrome)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to parkinsonian syndrome: Parkinsonism, Parkinson's disease

parkinsonian

 [pahr″kin-so´ne-an]
pertaining to parkinsonism.
parkinsonian syndrome any disorder manifesting the symptoms of parkinson's disease.

par·kin·so·ni·an

(par-kin-sō'nē-an),
Relating to or the suffering from parkinsonism (1).

parkinsonian

par·kin·so·ni·an

(pahr'kin-sō'nē-ăn)
Relating to or the suffering from parkinsonism (1).
References in periodicals archive ?
The other 2 had parkinsonian syndrome and were diagnosed as having CBD.
DAT imaging was considered positive for Parkinsonian syndrome in cases that had a reduction in [[sup.
Parkinsonian syndromes include neurodegenerative disorders such as Huntington's disease, and other acquired degenerative diseases such as progressive supranuclear palsy.
ALTROPANE molecular imaging agent is in Phase III clinical trials for the diagnosis of Parkinsonian Syndrome (PS) and a Phase II clinical trial for the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD).
Among the side effects attributed to valproic acid, parkinsonian syndromes and cognitive impairment were not commonly reported.
Lees, (Neuroimaging Help in the Diagnosis of Movement Disorders) and correlated well with Klaus Seppi MD*, Werner Poewe MD study on Brain Magnetic Resonance Imaging Techniques in the Diagnosis of Parkinsonian Syndromes, study of Mario Mascalchi, Alessandra Vella MD and Roberto Ceravolo MD on Role of Imaging in Diagnosis in movement Disorders and study of A.
Our results demonstrated that diagnoses of Parkinsonian syndromes are challenging and far from accurate, especially by nonmovement disorder specialists.
The radiolabeled dopamine transporter receptor is used with single-photon emission computed tomography imaging for potential differential diagnosis of Parkinsonian syndromes and Dementia with Lewy Bodies.
The distinction between Parkinson's disease (PD), other parkinsonian syndromes such as multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and LBD, and other conditions such as essential tremor, has important implications for treatment and prognosis.
has signed a three-year contract with Navidea Biopharmaceuticals to manufacture NAV5001, a diagnostic imaging agent used to detect Parkinsonian Syndromes and Dementia with Lewy Bodies.
The trial broadens the fields of application for EyeBrain Tracker, which is already used in the early diagnosis of Parkinsonian syndromes such as progressive supra-nuclear paralysis (PSP), cortico-basal degeneration (CBD) and multiple systems atrophy (MSA).
3) There have been few studies of visual field defects in patients with any of the Parkinsonian syndromes, a reflection of the specific difficulties of conducting such tests in patients with a movement disorder.